Visit Healeex

A Scalable Foundation for Health-Tech Products

Hybrid Plasma Technology is the foundation for a new generation of non-invasive energy-based health-tech products — from current wellness applications to natural longevity, education, research, manufacturing, and future regulated medical-product development.

Synergotron is building a platform, not just a product. Our project portfolio connects current commercial products, concept-stage developments, scientific collaboration, and the long-term development of future regulated medical applications.

Synergotron side picture

From Core Technology to Product Pathways

Synergotron develops product pathways around its patented Hybrid Plasma Technology platform.

Some projects are already commercial. Others are in concept development, research collaboration, or future regulated planning. Each project has its own purpose, market, development stage, and regulatory context.

We work with selected partners who may help transform deep technology into responsible, scalable, and market-ready products.

Synergotron side picture

Each project has its own purpose, market, development stage, and regulatory pathway.

Project Areas

Card image

Wellness & Body-Care

Healeex is Synergotron’s first commercial product powered by Hybrid Plasma Technology. It is designed as a non-invasive wellness device for personal and professional body-care routines, relaxation, everyday comfort, and general wellbeing.

As the first market-ready expression of our platform, Healeex demonstrates how non-invasive energy-based technology may be translated into a practical, user-friendly product format.

Healeex is intended for general wellness use only and is not a medical device.

Card image

Natural Longevity & Skin Vitality

Eeya is a premium concept exploring how Hybrid Plasma Technology may be adapted for gentle facial wellness, natural skin vitality, and long-term self-care rituals.

The concept is designed for people and brands who believe that beauty should not feel aggressive or superficial. Eeya focuses on natural-looking freshness, refined user experience, and a gentle, non-invasive approach to facial self-care.

Eeya is currently a concept-stage project for the longevity, skincare, beauty-tech, natural cosmetics, premium wellness, and lifestyle self-care markets.

Card image

Future Medical Products

Beyond current wellness products, Synergotron is working toward future regulated medical-product development based on Hybrid Plasma Technology.

These concepts are separate from current commercial wellness products. Any future medical product would require dedicated technical development, quality systems, safety and performance testing, clinical evaluation where applicable, and regulatory approval before regulated market use.

This direction reflects Synergotron’s long-term ambition: to advance non-invasive energy-based health technologies toward future certified medical products.

Card image

Scientific & Institutional Collaboration

Synergotron’s research pathway is designed for scientific, institutional, and expert collaboration around Hybrid Plasma Technology.

This area focuses on structured observation, parameter research, technical validation, safety documentation, user-experience evaluation, and future development planning. Research activities are separated from current commercial wellness communication and do not represent medical claims for current products.

We welcome collaboration with universities, research institutions, scientific advisors, biophysics experts, validation partners, and strategic R&D collaborators.

Card image

Professional Educational Ecosystem

Synergotron is developing a professional educational ecosystem to support responsible use, structured training, and consistent communication around its products.

This pathway includes user education, distributor onboarding, professional wellness integration, and future learning modules for different levels of use — including basic product guidance, performance-oriented wellness education, and integrative wellness concepts.

The goal is to create a scalable knowledge platform that supports users, professionals, partners, and international distributors with clear, compliant, and practical education.

Card image

Scale-Up and Strategic Partnerships

Hybrid Plasma Technology is not limited to one product or market. Synergotron is open to strategic cooperation with selected partners who may help scale the platform into multiple product families, markets, and regions.

Potential collaboration areas may include manufacturing scale-up, licensing, regional distribution, co-development, private-label concepts, investment, education, institutional collaboration, and global commercialization.

This pathway is intended for partners who see Hybrid Plasma Technology as a platform opportunity, not only as a single-device business.

Partner With Synergoton

Synergotron is developing Hybrid Plasma Technology as a platform for multiple non-invasive energy-based health-tech products — from current wellness applications to future regulated medical-product development.

We are open to selected partnerships with organizations that may help us scale, validate, distribute, manufacture, or commercialize our technology in strategically aligned markets.

We welcome inquiries from distributors, investors, manufacturing partners, wellness and longevity brands, education partners, research institutions, regulatory specialists, medical-device development partners, and licensing or co-development partners.

Synergotron side picture

Note:

This page provides a high-level corporate overview of Synergotron’s current products, concept-stage projects, research interests, and future development directions.

Healeex is currently positioned as a general wellness product and is not intended to diagnose, treat, cure, prevent, monitor, or alleviate any disease or medical condition. Eeya and other future concepts are presented as concept-stage or development-stage projects.

References to future regulated medical products, research activities, or clinical environments are provided for corporate and R&D context only and do not represent medical claims, clinical performance claims, or regulatory approval for any current product.

Background image for subscribe block

Stay Updated

Subtitle: Subscribe to receive Synergotron updates, technology insights, and partnership news directly in your inbox. By subscribing, you agree to our Privacy Policy.